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- Structural modeling of carboxylic acid reductase (CAR) MAB4714 revealed the 
residues of its carboxylate-binding pocket. 
- Succinate reductase activity of MAB4714 was increased by over 2-fold by 
mutating Leu284 or Thr285 to Trp. 
- The conserved Ser residue of the CAR phosphopantheteine attachment site is 
critical for protein stability in solution. 
 
Abstract 
Carboxylic acid reductases (CARs) catalyze ATP- and NADPH-dependent reduction of 
carboxylic acids to corresponding aldehydes. Although successful applications of these 
enzymes for the bioconversion of monocarboxylic acids have already been reported, their 
applicability for the reduction of dicarboxylic acids is not well understood. Here, we 
explored the possibility of engineering CARs for enhanced activity toward succinic acid 
for potential applications in 1,4-butanediol production. Structural models of the 
carboxylate-binding pocket of the CAR enzyme MAB4714 from Mycobacterium 
abscessus suggested that its reactivity toward succinic acid could be enhanced by 
reducing the pocket volume. Using site-directed mutagenesis, we introduced larger side 
chains into the MAB4714 carboxylate binding pocket and compared the activity of 16 
mutant proteins against cinnamic and succinic acids. These experiments revealed that, 










increased activity toward succinic acid more than two times. The T285E mutant protein 
also showed increased activity toward succinic acid, but it was lower than that of T285W. 
The mutated residues of MAB4714 are located on the flexible loop covering the 
carboxylate-binding pocket, which appears to contribute to substrate preference of CARs. 
Thus, reductase activity of CARs against succinic acid can be improved by introducing 
large side chains into the carboxylate-binding pocket. We also discovered that alanine 
replacement of the conserved Ser713 in the CAR phosphopantetheine attachment site 
resulted in complete degradation of the full-length protein into separate A and R domains, 
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Carboxylic acids serve as precursors for a broad range of commodity chemicals and 
polymers. Their importance for the chemical industry has been underlined in the US DoE 
list of the top 12 platform chemicals, which includes nine organic acids (Bozell, 2010; 
Jang et al., 2012). Many carboxylic acids are available in great abundance as renewable 
feedstocks including succinic acid, citric acid, and ferulic acid (Napora-Wijata et al., 
2014). Bio-based production of organic acids has become a rapidly growing field due to 
recent advances in metabolic engineering and synthetic biology (Alonso et al., 2015; 
Bornscheuer et al., 2012). Increasing production of carboxylic acids from renewable 
resources makes them attractive precursors for a broad range of valuable products such as 
polymers, aldehydes, and alcohols. However, chemical reduction of carboxylic acids to 
aldehydes is an energetically demanding reaction, which is also difficult to control 
because of the low energy barrier for the further reduction to an alcohol. Although many 
advances in chemocatalytic reduction have been reported, these methods usually depend 
on activated carboxylates, require harsh reaction conditions, and produce considerable 
amounts of toxic waste. Biocatalytic reduction of carboxylic acids offers the typical 
advantages of enzyme-catalyzed processes, including chemoselectivity, 
enantioselectivity, and mild reaction conditions (Hollmann, 2011; Napora-Wijata et al., 
2014). Therefore, biocatalytic reduction of organic acids is gaining importance. 
      Currently, several biological routes to carboxylic acid reduction are known including 
direct reduction, catalyzed by a single enzyme or two-enzyme cascades with thioester or 
phosphoester intermediates (Kramer et al., 2018; Napora-Wijata et al., 2014). 










plants) catalyze the reduction of a carboxylate substrate to the corresponding aldehyde 
using ATP and NADPH as cofactors (Gross, 1969; Li and Rosazza, 1997). In the first 
step, these enzymes catalyze the initial reaction between a carboxylic acid and ATP 
producing an acyl-AMP intermediate, which is then reduced by NADPH to form the 
aldehyde product. Biochemical studies with the purified CAR from Nocardia iowensis 
demonstrated a large protein (over 1,000 residues) with three domains: an N-terminal 
adenylation (A) domain, a C-terminal reductase (R) domain with a phosphopantetheine 
attachment site, and a trans-thiolation domain (T), also called PCP, peptidyl carrier 
protein located between them (He et al., 2004; Li and Rosazza, 1998; 
Venkitasubramanian et al., 2007). For maximal activity, the recombinant N. iowensis 
CAR required post-translational phosphopantetheinylation at a conserved Ser residue in 
the T-domain by a phosphopantetheinyl transferase (added as a purified protein or co-
expressed in E. coli) (Venkitasubramanian et al., 2007). The detailed mechanism of the 
CAR reaction cascade from acid to aldehyde is not fully understood (Winkler, 2018). The 
proposed catalytic model of CAR reaction suggests that the deprotonated acid is activated 
by ATP at the A-domain producing an acyl-AMP intermediate, which is nucleophilically 
attacked by the phosphopantetheine thiol, with the formation of covalently bound acyl 
thioester and AMP (He et al., 2004; Venkitasubramanian et al., 2007; Winkler, 2018). 
The acyl thioester-phosphopantetheine moiety then moves from the A-domain to the R-
domain, where the acyl thioester is reduced by NADPH producing a free aldehyde and 
enzyme. The recent determination of crystal structures for individual domains and their 
combinations (A-T and T-R) of three CARs from Segniliparus rugosus (SrCAR), 










breakthrough in our understanding of the molecular mechanisms of CAR activity and 
substrate selectivity (Gahloth et al., 2017). The structures of CARs revealed large-scale 
domain motions during the reaction, and suggested that molecular interactions between 
the A and R domains are limited to competing T-docking sites. These studies also 
identified the presence of a mobile C-terminal sub-domain in the A domain of bacterial 
CARs which adopts distinct positions(Gahloth et al., 2017). Structure-based site-directed 
mutagenesis of CARs from S. rugosus and Neurospora crassa identified several residues 
critical for catalytic activity of these enzymes (Gahloth et al., 2017; Stolterfoht et al., 
2018).  
         Purified CARs from different organisms have been shown to accept a broad range 
of carboxylic acids as substrates with some enzymes being more promiscuous than others 
(Akhtar et al., 2013; Finnigan et al., 2017; Khusnutdinova et al., 2017; Li and Rosazza, 
1997; Napora-Wijata et al., 2014; Winkler, 2018). A recent detailed kinetic analysis of 
CARs suggested that substrate preference of these enzymes is determined by the first step 
in the proposed reaction mechanism (formation of acyl-AMP intermediate), which is an 
ordered sequential Bi Bi reaction with ATP bound before the carboxylate substrate 
(Finnigan et al., 2017). The substrate profiles of characterized CARs largely overlap and 
include aromatic, heteroaromatic, and aliphatic (from C2 to C18) carboxylic acids, as 
well as bifunctional carboxylic acids (diacids, hydroxyacids, oxoacids, and amino acids) 
(Khusnutdinova et al., 2017; Kramer et al., 2018). With monocarboxylic acids as 
substrates, purified CARs exhibited significant reductase activity toward C3-C16 
substrates with maximal activity against C4-C12 acids (Akhtar et al., 2013; 










containing additional polar or charged groups (hydroxy, oxo, carboxy, or amino) 
(Khusnutdinova et al., 2017; Kramer et al., 2018). Nevertheless, CARs can tolerate the 
presence of a second charged or polar group in their substrates.  
      The broad substrate scope and kinetic characteristics of CARs suggest the potential 
for their application as industrial biocatalysts (Finnigan et al., 2017; Winkler, 2018). 
Several successful applications of CARs have already been demonstrated for the 
microbial production of alkanes, propane, and aromatic aldehydes (Akhtar et al., 2013; 
Kallio et al., 2014; Kunjapur et al., 2014; Schwendenwein et al., 2016; Sheppard et al., 
2016; Sheppard et al., 2014). Interestingly, MavCAR from Mycobacterium avium and 
MarCAR from Mycobacterium aromaticivorans have been shown to be active towards 
both succinic and lactic acid, which are central microbial metabolites (Kramer et al., 
2018). Succinic acid can be biocatalytically transformed to 1,4-butanediol (1,4-BDO) 
using the heterologous biosynthetic pathway established in E. coli by Genomatica (Fig.1) 
(Yim et al., 2011). 1,4-BDO is an important non-natural chemical, which is used as a 
precursor for the synthesis of different polymers. The reported 1,4-BDO pathway (from 
succinate to 1,4-BDO) includes six enzymes, and produces 4-hydroxybutyrate as an 
intermediate (Yim et al., 2011). Recently, we demonstrated that several CARs including 
MAB4714 from Mycobacterium abscessus exhibit significant reductase activity toward 
4-hydroxybutyrate, producing 4-hydroxybutanal as the product (Khusnutdinova et al., 
2017). Using various combinations of CARs and aldo-keto reductases, we observed up to 
95% conversion of 4-hydroxybutyrate to 1,4-BDO (Khusnutdinova et al., 2017), 
suggesting that the reported 1,4-BDO pathway can be shortened to five enzymes using 










engineered to catalyze two sequential reductions of carboxylate groups to corresponding 
alcohols (Gahloth et al., 2017), suggesting that engineered CARs might be able to 
directly reduce succinic acid to 1,4-BDO (Fig. 1). The objective of the present study was 
to use protein engineering to enhance MAB4714 activity toward succinate for the 
production of 1,4-BDO in combination with aldo-keto reductases (Fig. 1, the left 
pathway). We performed structural analysis (modeling) of MAB4714 to explore the 
feasibility of minimizing the carboxylate-binding pocket of this enzyme in order to 
increase its activity toward succinic acid. Using site-directed mutagenesis, we generated 
16 MAB4714 mutant variants, and identified two variants with enhanced reductase 
activity toward succinic acid. We also investigated stability of purified CARs and the 
effect of protein expression conditions on CAR activity.   
 
2. Materials and methods 
2.1. Gene Cloning and Protein Purification 
The genes encoding carboxylic acid reductases MAB4714 (Uniprot ID B1MLD7) and 
MSM5586 (Uniprot ID I7GER2) were amplified using PCR from genomic DNA of 
Mycobacterium abscessus and M. smegmatis, respectively, and cloned into a modified 
p15TVLic vector (Novagen) encoding an N-terminal 6His-tag as described previously 
(Kuznetsova et al., 2006). The phosphopantetheinyl transferase (PPT) BSU03570 (Sfp) 
from Bacillus subtilis was cloned into a pCDFDuet plasmid (without affinity tags) for co-
expression with CARs in Escherichia coli. All plasmids were transformed into the 










in 1 L cultures (on TB medium) to OD600 0.7 – 1.0, and protein expression was induced 
by the addition of 0.4 mM IPTG followed by overnight incubation at 26 °C (Table 1). 
Recombinant proteins were purified to near homogeneity (>95%) using Ni-chelate 
affinity chromatography on Ni-NTA Superflow resin (Qiagen) using standard protocols. 
Protein purity was analyzed using electrophoresis in 10% SDS polyacrylamide gels 
(SDS-PAGE). Site-directed mutagenesis of MAB4714 and MSM5586 was performed 
using the QuikChange™ site-directed mutagenesis kit (Stratagene) according to the 
manufacturer's protocol, and mutations were verified by DNA sequencing. 
2.2. Enzymatic Assays 
Carboxylate reductase activity against different carboxylic acids was determined 
spectrophotometrically using an NADPH oxidation-based assay by following the 
decrease in absorbance at 340 nm (ε340 = 6.22 mM-1×cm-1) using a SpectraMax M2 plate-
reader (triplicate assays in 96-well plates). CAR activity assays were performed at 30 °C 
in a reaction mixture (0.2 ml) containing 100 mM HEPES-K buffer (pH 7.5), 2 mM 
NADPH, 2.5 mM ATP, 10 mM MgCl2, substrate (10 mM for aliphaticS acids, 2 mM 
cinnamic acid, or 100 mM succinic acid), and 5-10 μg of purified enzymes. The kinetics 
of MAB4714 were determi ed from specific activities over a range of substrate 
concentrations using 5-100 µg of purified proteins. The kinetic parameters (Km and kcat) 
were calculated by nonlinear regression analysis of raw data fit from Lineweaver-Burk 
plots using GraphPad Prism software (version 5.00 for Windows, GraphPad Software, 
San Diego, CA). 










Protein stability of purified CARs (MSM5586 wild type and S713A mutant proteins) was 
analyzed using SDS-PAGE after incubation in the presence of different compounds (2 
mM): ATP, ADP, CTP, polyphosphate, cinnamic acid, cinnamaldehyde, NADP, or 
NADPH. CAR samples (1.4 mg/ml) were incubated in 20 mM HEPES-K buffer (pH 7.5) 
containing 200 mM NaCl at room temperature for 30 h, and protein aliquots (5 µg) were 
analyzed using SDS-PAGE (10%). Effect of different compounds (Table 2) on stability 
of purified CAR was determined using MAB4714 (1 mg/ml) in 100 mM HEPES-K 
buffer (pH 7.5). After 16 h of incubation at 30 °C, the remaining CAR activity was 
measured in a reaction mixture containing 100 mM HEPES-K (pH 7.5), 5 mM benzoic 
acid, 10 mM MgCl2, 1.5 mM ATP, and 0.4 mM NADPH. 
2.4. Bioinformatics and Protein Modeling 
Multiple sequence alignments of CARs were generated using the MAFFT online service 
(Katoh et al., 2017) and STRAP tool (Gille et al., 2014). Structural models of the 
MAB4714 A-domain were generated using the Phyre 2 web portal for protein modeling 
(Kelley et al., 2015). The MAB4714 models were built based on the recently determined 
crystal structures of the Segnillip rus rugosus CAR (SrCAR, PDB codes 5MST and 
5MSS, confidence 100%, sequence identity 59%). The substrate binding pockets of 
CARs was analyzed using PyMol version 2.4. 
 
 
3. Results and discussion 










Enzyme stability is of paramount importance in many biocatalytic processes (Littlechild, 
2015; Lorenz and Eck, 2005). CARs are large proteins with two separate domains 
connected by a flexible linker (Fig. 2), but their stability is not well understood. The 
previous work with M. marinum CAR suggested that it is a relatively stable enzyme, with 
in vitro half-life of 48 h at 37 °C (Akhtar et al., 2013). However, the recent study with 
five different CARs revealed a broad range of stability, with half-life at 30 °C ranging 
from 25 h to 123 h depending on the organism (Finnigan et al., 2017). In this work, we 
found that purified MAB4714 lost most of its catalytic activity after overnight storage at 
4 °C (data not shown). Flash freezing in liquid nitrogen and subsequent storage at -80 °C 
reduced MAB4714 activity by ~30% (Table 1), but the frozen sample retained the 
remaining activity for several weeks (data not shown). We also determined the effect of 
different chemicals on stability of purified MAB4714 at 30 °C. After 16 hours of 
incubation at 30 °C, the control sample (no additions) retained 88% of initial activity 
indicating that MAB4714 is more stable at this temperature than at 4 °C (Table 2). The 
addition of DMSO, divalent cations (Ca2+, Mg2+), and diols (1,4-butanediol, 1,6-
hexanediol) had destabilizing effects on MAB4714, with remaining activity 53-71%. 
Moderate stabilizing effects were observed in the presence of 10 mM polyphosphate 
(91.5% remaining activity), 10% glycerol (94%), and 150 mM NaCl (97%) (Table 2).    
      Recombinant expression of microbial CARs is not a trivial task, because these large 
proteins (over 1,000 amino acids) require post-translational modification via 
phosphopantetheinylation by a co-expressed phosphopantetheinyl transferase (PPT). 
Most published studies used the Bacillus subtilis BSU03570 (Sfp) for activation of 










Indeed, our recent work demonstrated that this PPT enzyme produced slightly better 
results than the E. coli EntD when co-expressed with different CARs (Khusnutdinova et 
al., 2017). The optimal conditions for recombinant expression of Mycobacterium phlei 
CAR (MpCAR) in E. coli cells have been determined as induction with 0.15 mM IPTG at 
OD600 = 0.6 followed by incubation (~18 h) at 20 °C (Finnigan et al., 2017). Similar 
expression conditions were found to be suitable for the recombinant expression of CARs 
from other organisms (Finnigan et al., 2017). In addition, several CARs were successfully 
produced using the auto-induction protocol described by Studier, which is based on the 
induction of protein expression by lactose (instead of IPTG) (Stolterfoht et al., 2017; 
Studier, 2005). The optimized protocol for recombinant expression and affinity 
purification of proteins from different organisms in E. coli developed by structural 
genomics projects includes growing E. coli cells at 37 °C to OD600 = 0.6 – 1.0 followed 
by IPTG induction (0.2 – 1.0 mM) and overnight incubation of cultures at 15 - 25 °C 
(Structural Genomics et al., 2008). It has been proposed that lower incubation 
temperatures facilitate proper fording of recombinant proteins during induction 
(Structural Genomics et al., 2008). In our standard protocol for recombinant protein 
expression and purification, the overnight incubation temperature is shifted to 16 °C 
(from 37 °C) after IPTG induction (Kuznetsova et al., 2006). When applied to MAB4714, 
this method produced 5-30 mg of purified enzyme (from 1 L cultures) with specific 
activities 0.4-0.6 U/mg (Table 1). Since this method produced large batch variations, we 
compared it with two modified protocols with higher induction temperatures (26 °C and 
37 °C) and shorter incubation times (12 h and 5 h, respectively). As shown in Table 1, 










effect on CAR activity, whereas induction at 26 °C for 12 h produced more active 
MAB4714 (~1 U/mg) with more reproducible protein yields (12-18 mg). Therefore, this 
protocol was used for recombinant expression and purification of CARs.    
 
3.2. Analysis of the substrate-binding site of MAB4714 
Both SrCAR and MAB4714 belong to sub-group II of bacterial CARs (Khusnutdinova et 
al., 2017), and share 61.5 % sequence identity at the amino acid level. Sequence analysis 
of microbial CARs revealed over 300 conserved residues with up to 160 residues in their 
A-domains (including the AMP-binding motif YTSGSTGxPKG), 25 residues in the PCP 
domain, and 170 in the R-domain (Finnigan et al., 2017; Stolterfoht et al., 2017; 
Stolterfoht et al., 2018) (Fig. 2A). Previous biochemical studies and crystal structures of 
CARs suggested that A domains (Fig. 2A) play a major role in substrate recognition by 
these enzymes (Finnigan et al., 2017; Gahloth et al., 2017; Stolterfoht et al., 2018; Wang 
and Zhao, 2014). Recent mutational studies with the Neurospora crassa CAR (NcCAR) 
identified several amino acid residues of the A-domain critical for catalytic activity, 
including His237, Glu337, and Glu433, whereas alanine replacement mutations of 
Thr336, Asp405, and Arg422 resulted in a strong decrease in activity (Stolterfoht et al., 
2017; Stolterfoht et al., 2018). However, the latter three residues appear to be not 
conserved in bacterial CARs, which share rather low sequence similarity with fungal 
CARs (~25% sequence identity). Nevertheless, the NcCAR His237 is homologous to 
His315 in SrCAR and His300 in NiCAR, which are positioned close to both the AMP 










domains in complex with AMP and acid substrates (benzoic acid or fumarate) revealed 
the relatively narrow substrate binding pocket lined by hydrophobic residues with the 
catalytic His (His300 in NiCAR and His315 in SrCAR) located at the bottom (Gahloth et 
al., 2017). The substrate binding pockets of SrCAR and NiCAR have different volumes 
and shapes, suggesting some differences in substrate preference of these CARs.  
      Using the Phyre2 web portal for protein modeling (Kelley et al., 2015), we generated 
a high quality structural model of MAB4714 (A-domain), which is based on the crystal 
structure of SrCAR in complex with AMP and fumarate (PDB code 5MST; confidence 
100%, 640 amino acids, 59% sequence identity) (Fig. 3). The model of the MAB4714 A-
domain revealed a potential carboxylate-binding pocket located near the conserved 
His301 (His315 in SrCAR) (Fig. 3). This pocket accommodates mostly hydrophobic 
residues, including Leu284, Thr285, Ala303, Leu306, Leu342, which might be involved 
in substrate recognition and binding (Fig. 3). In addition, there are at least five Gly 
residues in the MAB4714 substrate-binding pocket (Gly393, Gly395, Gly418, Gly420, 
Gly426), with three of them also conserved in SrCAR (Gly405, Gly407, Gly432) (Fig. 3). 
In the MAB4714 sequence, these residues are located within the Acore domain, between 
the AMP-binding motif and the Asub domain (Fig. 2A). A recent computational analysis 
of the SrCAR structure suggested that conserved Thr265 (Thr258 in MAB4714), Ser408 
(Ser396 in MAB4714), and Thr505 (Thr493 in MAB4714) might play an important role 
in substrate recognition (Qu et al., 2019). In the MAB4714 A-domain model, Thr258 and 
Thr493 are positioned outside of the carboxylate-binding pocket, whereas Ser396 is 
located at the bottom of the carboxylate-binding pocket near the conserved His301, 










      We hypothesized that binding of succinic acid in the MAB4714 active site might be 
facilitated by the reduction of the volume of carboxylate-binding pocket, e.g. by 
replacing small residues or glycines with larger side chains (hydrophobic or non-polar). 
Based on the MAB4714 structural model (Fig. 4), we selected nine residues 
(hydrophobic, polar, or Gly) located near the distal (to His301) end of the pocket and 
mutated them to larger hydrophobic residues (Trp, Phe, Leu) using site-directed 
mutagenesis. As controls, we also introduced polar (Gln) or negatively charged (Glu) 
residues to several positions. Sixteen clones produced soluble mutant proteins, which 
were affinity purified and assayed for carboxylate reductase activity with cinnamic acid 
and succinic acid as substrates (Fig. 5). 
   
3.3. Carboxylate reductase activity of MAB4714 mutant proteins 
      For purified wild type MAB4714, carboxylate reductase activity against cinnamic 
acid was approximately 500 times higher than that toward succinic acid (Fig. 5).  The 
replacement of Gly420 with Trp or Glu completely abolished reductase activity of 
MAB4714 against cinnamic acid. With succinic acid as substrate, G420W retained wild-
type activity, whereas the activity of G420E was two times lower (Fig. 5). This suggests 
that the introduction of a bulky side chain at the position of Gly420 prevents binding of 
aromatic substrates in the MAB4714 active site but has minor effects on succinic acid 
binding. Cinnamic acid reductase activity was unaffected in the MAB4714 mutant 
proteins T285E, A303L, L306W, L342F, L342E, L342Q, G395E, and G426W, slightly 










G395L (Fig. 5). In NcCAR, alanine replacement of Lys190 and Pro234 increased its 
reductase activity toward cinnamic acid (Stolterfoht et al., 2017). However, none of the 
MAB4714 mutant proteins obtained in this work showed increased activity with 
cinnamic acid (Fig. 5). 
      With succinic acid as substrate, most MAB4714 mutant proteins showed reduced 
reductase activity, including A303L, A303E, L306W, L342F, L342E, G395L, G395E, 
G418E, G420W, and G420E, while G426W had wild-type activity (Fig. 5). In the 
MAB4714 A-domain structural model, these residues are located at the bottom or middle 
of carboxylate-binding pocket, near the catalytic His301 (4 – 13 Å) (Fig. 4). This area 
seems to be more critical for succinate binding compared to cinnamic acid (except for 
Gly420). However, succinate reductase activity was increased by ~ 50% in T285E and 
L342Q proteins, whereas L284W and T285W were found to be at least two times more 
active than wild type MAB4714 (although the reaction rates remain low) (Fig. 5). 
Analysis of kinetic parameters of L284W and T285W with cinnamic acid as a substrate 
revealed that they had lower Km values compared to the wild-type MAB4714, but their 
kcat were similar (for T285W) or lower (for L284W) (Table 3). With succinic acid as 
substrate, we were unable to get accurate determinations for wild-type MAB4714, but the 
observed kcat values for L284W and T285W (0.16-0.20 s-1) were approximately two times 
higher than that reported for MarCAR and MavCAR (Kramer et al., 2018). However, the 
affinity of both L284W and T285W to succinic acid was at least three orders of 
magnitude lower than to cinnamic acid indicating that more work is required to improve 










      As shown in Fig. 5, replacement of Leu284 and Thr285 by Trp (Fig. 4) had positive 
effects on the MAB4714 activity against succinic acid. The results suggest that these 
mutations appear to reduce the volume of carboxylate-binding pocket facilitating binding 
of succinic acid. This is in line with the side chain orientation of the homologous Ala293 
and Phe294 (Leu284 and Thr285 in MAB4714, respectively) in the structure of the 
SrCAR-fumarate complex (PDB code 5MST, Fig. 3B). In bacterial CARs, these residues 
are located on a flexible loop of variable length (9-14 aa) connecting the α helix-14 and β 
strand-10 in the SrCAR structure (PDB code 5MSS) and accommodating mostly non-
conserved residues (Fig. 2). In a recent study with NcCAR, replacement of Pro234 or 
Pro285 by Ala elevated the activity of this enzyme against longer aliphatic acids, 
probably due to the increased flexibility of the associated secondary structures 
(Stolterfoht et al., 2018). Based on the MAB4714 A-domain structural model, the 
carboxylate-binding pocket contains the highly conserved Pro290 (located on the 
Leu284-Thr285 loop) and conserved Pro298 (located near the catalytic His301) (Fig. 2). 
These Pro residues, as well as the residues of the Leu284-Thr285 loop and near Leu342 
(and their combinations) represent attractive targets for future protein engineering studies 
on MAB4714. 
 
3.4. Role of CAR phosphopantetheinylation in protein stability 
      Covalent modification of CARs via phosphopantetheinylation has been shown to be 
necessary for catalytic activity of these enzymes (Venkitasubramanian et al., 2007). 










stability. In preliminary crystallization studies with different CARs (including 
MAB4714), we were able to crystallize the CAR enzyme MSM5586 (A domain) from 
Mycobacterium smegmatis (but not MAB4714). In order to improve crystal quality, we 
generated the S713A mutant variant of MSM5586 to produce a more uniform protein 
preparation containing only unmodified CAR molecules. This Ser residue is conserved in 
all CARs and represents the attachment site for the phosphopantetheinyl arm involved in 
the transfer of catalytic intermediate from A-domain to R-domain (Gahloth et al., 2017). 
As shown in Fig. 6, freshly purified MSM5586 S713A variant had electrophoretic 
mobility on 10% SDS-gels similar to that of the wild-type protein, producing one major 
band with apparent Mr 130 kDa (calculated Mr 129.9 kDa). After 30 hours of incubation 
at room temperature, the wild-type MSM5586 showed no visible protein degradation 
(Fig. 6). In contrast, purified S713A mutant protein was almost completely degraded, 
with the formation of two major products of apparent Mr 75 kDa and 55 kDa (Fig. 6). 
Molecular masses of these products suggest that the MSM5586 polypeptide chain was 
broken within the PCP domain near Ser713 producing the separate A-domain (~ 1-712 
aa, calculated Mr 77.1 kDa) and R-domain (~ 713-1,193 aa, calculated Mr 52.8 kDa). 
Addition of ATP or CTP had moderate stabilizing effects on S713A, whereas other 
additions (ADP, AMP, pyrophosphate, cinnamic acid, cinnamaldehyde, NADPH) had no 
effect. Addition of NADP to purified S713A resulted in strong protein precipitation, and 
SDS-PAGE showed no apparent MSM5586 degradation (Fig. 6), suggesting that 
precipitated S713A is more stable than that in solution. All tested compounds had no 
effect on the stability of wild type MSM5586 (Fig. 6A). These results suggest that 










solution (and probably in vivo in E. coli cells). Thus, the presence of phosphopantetheinyl 
group in CARs seems to bе essential for stability of these enzymes in vitro.  
  
4. Conclusions 
      In this work, we performed structural analysis of the carboxylate binding pocket of 
MAB4714 and suggested that its activity toward succinic acid can be increased by 
reducing the pocket volume. Using site-directed mutagenesis, we introduced larger side 
chains to various positions of the MAB4714 carboxylate-binding pocket and determined 
catalytic activity of purified mutant proteins against cinnamic acid and succinic acid. We 
found that, although the reaction rates remain low, the replacement of Leu284 and 
Thr285 with Trp increased reductase activity of MAB4714 toward succinic acid more 
than two times. These results suggest that this locus and potentially other residues on this 
strand (Lys281 – Ser291) represent attractive targets for future protein engineering 
studies toward enhanced activity of CARs against succinic acid. We also demonstrated 
that phosphopantetheinylation of CARs is important for stability of purified proteins in 
solution, which can also be stabilized by the addition of NaCl, polyphosphate, and 
glycerol. The obtained MAB4714 variants can be used as starting material for future 
protein engineering efforts aimed at improving the activity of CARs against succinic acid 
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Fig. 1. The biocatalytic conversion of succinate to 1,4-BDO. Schematic diagram showing 
enzymatic reactions for the biotransformation of succinate to 1,4-BDO. The right part 
shows the reactions constituting the engineered pathway for 1,4-BDO biosynthesis from 
succinate demonstrated by Yim et al. (Yim et al., 2011). The numbered steps represent 
the following enzymes: (1), succinyl-CoA synthetase; (2), CoA-dependent succinate 
semialdehyde dehydrogenase; (3), 4-hydroxybutyrate dehydrogenase; (4), 4-
hydroxybutyryl-CoA transferase; (5), 4-hydroxybutyryl-CoA reductase; (6), alcohol 












Fig. 2. Domain organization of MAB4714 and sequence alignment of CAR A-domains. 
(A), Domain organization of MAB4714. Adenylation domain (A-domain core and A-sub-
domain), PCP (peptidyl carrier protein domain, phosphopantetheine attachment site), 
reductase domain (R-domain). Domain boundaries are indicated by residue numbers 
(above the diagram). (B), Sequence alignment of A-domains of MAB4714 and four other 
CARs. Conserved residues are shown in bold, whereas the AMP-binding motif is colored 
orange. The MAB4714 residues mutated in this work are shown in red and numbered, 
and the residues from the SrCAR substrate binding site are colored blue and numbered. 
The sequence alignment includes the following CARs: SrCAR (S. rugosus, Uniprot ID 
E5XP76), NiCAR (N. iowensis, Q6RKB1), MCH22995 (M. chelonae, A0A0E3TT64), 











Fig. 3. Structural analysis of the CAR carboxylate-binding pocket. (A), Crystal structure 
of the S. rugosus CAR (SrCAR) A domain in complex with fumarate and AMP (PDB 
code 5MST) (Gahloth et al., 2017). The overall fold of domain is shown in semi-
transparent surface representation to reveal the bound ligands and secondary structural 
elements. (B), Close-up view of the substrate-binding pocket showing bound AMP and 










carbons, whereas side chains of SrCAR are shown as sticks with brown carbons and 
labeled. The black labels indicate the corresponding residues of MAB4714 identified 
based on sequence alignment with SrCAR (Figure 2). 
 
Fig. 4. Structural models of substrate-binding pocket of MAB4714. (A), Close-up view 
of the wild-type carboxylate-binding pocket showing catalytic His301 and residues 
mutated in this work. (B), Carboxylate-binding pocket of the L284W mutant protein. (C), 
Carboxylate-binding pocket of the T285W mutant protein. The MAB4714 structural 
model was generated using the Phyre2 portal (Kelley et al., 2015) and is based on the 
structure of SrCAR (PDB code 5MSS, sequence identity 59%, confidence 100%). Protein 












Fig. 5. Site-directed mutagenesis of MAB4714: carboxylate reductase activity of purified 
wild-type and mutant proteins. (A), Cinnamic acid as substrate. (B), Succinic acid as 
substrate. Enzyme activities were determined by following NADPH oxidation in a 
reaction mixture containing 100 mM HEPES-K buffer (pH 7.5), 0.5 mM NADPH, 2.5 
mM ATP, 10 mM MgCl2, 2 mM cinnamic acid (or 100 mM succinic acid), and 3-5 μg of 











Fig. 6. Mutation of MSM5586 Ser713 to Ala reduces CAR stability in solution. 
Coomassie-stained SDS-gels showing purified wild-type (A) and S713A mutant (B) 
proteins after 30 h of incubation at room temperature. Molecular weight markers are 
shown on the left sides of gels, whereas apparent Mr of the two major degradation 































Table 1. Effect of protein storage and expression conditions on reductase activity of 
purified MAB4714 with cinnamic acid (2 mM) as substrate. 
Protein storage conditions Activity, U/mg 
Control (initial activity) 1.56 ± 0.03 
-80 °C, 1 day, no additions 1.05 ± 0.03 
-80 °C, 1 day, 5 mM DTT 0.43 ± 0.02 
-80 °C, 6 days, no additions 0.90 ± 0.03 
Protein expression conditions  
(after IPTG addition) 
Incubation for 20 hours at 16 °C 0.53 ± 0.09 (16.4 ± 11.6)a 
Incubation for 12 hours at 26 °C 1.05 ± 0.03 (15.5 ± 3.3) 
Incubation for 5 hours at 37 °C 0.41 ± 0.05 (6.5 ± 1.2) 
 
a Numbers in brackets indicate CAR protein yield (mg/L of E. coli culture).  
 
 
Table 2.   Stability of purified MAB4714: reductase activity after incubation with 
different compoundsa.  
Compounds Concentration Residual activity, % 
1. No addition N/Ab 88.1±2.3 
2. MgCl2 10 mM 73.9±8.1 
3. CaCl2 10 mM 53.3±1.5 
4. EDTA 1 mM 82.6±19.0 
5. DMSO 1 % 64.8±7.6 
6. TCEP 0.5 mM 78.4±1.8 
7. Citrate Na 50 mM 75.5±6.2 
8. Formate Na 50 mM 66.9±2.7 
9. Formate Na 100 mM 67.1±3.2 
10. Polyphosphate 1 mM 72.7±3.0 
11. Polyphosphate 5 mM 72.8±11.4 










13. Glycerol 10 % 93.9±2.8 
14. NaCl 50 mM 92.3±3.5 
15. NaCl 150 mM 97.3±6.3 
16. NaCl 250 mM 89.6±1.1 
17. NaCl 350 mM 84.8±1.0 
18. NaCl 450 mM 82.5±4.7 
19. KCl 50 mM 82.5±12.9 
20. KCl 150 mM 86.2±6.7 
21. KCl 250 mM 84.8±2.7 
22. KCl 350 mM 88.5±4.8 
23. KCl 450 mM 91.5±4.4 
24. 1,4-butanediol 10 mM 62.0±4.7 
25. 1,6-hexanediol 10 mM 71.2±6.4 
 
a Purified MAB4714 (1 mg/ml) was incubated for 16 h at 30°C with indicated 
compounds, and residual reductase activity was measured using 5 mM benzoic acid as 
substrate (in 0.1 M Hepes-K, pH 7.5,10 mM MgCl2, 1.5 mM ATP, 0.4 mM NADPH, at 
30°C). Activities are presented as % of the initial activity before incubation with 
compounds (100% = 3.7 ± 0.1 U/mg). 




Table 3. Kinetic parameters of purified wild type and mutant MAB4714 proteins with 









cinnamic acid wild type 0.56 ± 0.07 1.95 ± 0.07 0.4 × 104 
L284W 0.35 ± 0.06 1.56 ± 0.02 0.5 × 104 
T285W 0.27 ± 0.03 2.07 ± 0.07 0.8 × 104 
succinic acid wild type 545 ± 166 0.12 ± 0.02 0.3 
L284W 161 ± 17 0.20 ± 0.01 0.1 × 101 
T285W 336 ± 34 0.16 ± 0.01 0.1 × 101 
 
 
